ADMA Biologics Inc — movimiento trimestral de fondos (NASDAQ:ADMA) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Activos totales 488.68 M510.57 M558.38 M568.69 M624.24 M Total de pasivos 139.66 M137.15 M160.06 M137.5 M146.92 M Capital total 349.02 M373.42 M398.32 M431.19 M477.32 M Total de pasivos y patrimonio neto 488.68 M510.57 M558.38 M568.69 M624.24 M Deuda total 72.34 M72.53 M73.4 M72.43 M72.14 M Deuda neta -30.81 M902 K-16.89 M11.04 M-15.49 M

Noticias

ADMA Crashes 42.5% YTD: Right Time to Buy the Stock?

TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication

NVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

Is ADMA Poised for Margin Growth and Supply Expansion in 2026?

Adma Biologics (ADMA) Laps the Stock Market: Here's Why

ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA)

Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?

NVO Launches Wegovy Subscription Plan, Boosts Access, Stock Up

Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio

Incyte Reports Strong 54-Week Data From Late-Stage Skin Disorder Study

ADMA Biologics: Differentiated Plasma Approach With Asymmetric Upside Potential (Upgrade)